Michael F. Demane - Mar 31, 2022 Form 4 Insider Report for NEVRO CORP (NVRO)

Role
Director
Signature
/s/ Kashif Rashid, as Attorney-in-Fact for Michael DeMane
Stock symbol
NVRO
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4
Date filed
4/4/2022, 09:46 PM
Previous filing
Jan 4, 2022
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVRO Common Stock Award $0 +362 +0.91% $0.00 40.1K Mar 31, 2022 Direct F1, F2
holding NVRO Common Stock 149K Mar 31, 2022 See footnote F3
holding NVRO Common Stock 72K Mar 31, 2022 See footnote F4
holding NVRO Common Stock 11.6K Mar 31, 2022 See footnote F5
holding NVRO Common Stock 48K Mar 31, 2022 See footnote F6
holding NVRO Common Stock 49.9K Mar 31, 2022 See footnote F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested restricted stock. The restricted stock represent quarterly retainer fees that the Reporting Person elected to receive in the form of shares of common stock in lieu of cash.
F2 Includes 1,167 restricted stock units.
F3 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
F4 Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2017 Family SLAT Trust U/A/D May 22, 2017.
F5 Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees, Michael F. DeMane Revocable Trust U/A 10/07/2011.
F6 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 04/23/2021.
F7 Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2021 Retained Annuity Trust U/A 08/13/2021.